Integrated serum screening for Down syndrome in primary obstetric practice

Prenatal Diagnosis

Volumn 25, Issue 12, 2005, Pages 1162-1167

  Knight, George J ^a,b   Palomaki, Glenn E ^a,b   Neveux, Louis M ^a,b   Smith, Dwight E ^a   Kloza, Edward M ^a   Pulkkinen, Andrea J ^a   Williams, Josephine ^a   Haddow, James E ^a,b  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Down syndrome; Integrated serum test; Intervention trial; Prenatal screening

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FETUS; FETUS RISK; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT; NUCHAL TRANSLUCENCY MEASUREMENT; OBSTETRICS; PERFORMANCE; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CONFIDENCE INTERVALS; DOWN SYNDROME; ESTRIOL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INHIBINS; MAINE; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PRIMARY HEALTH CARE; PRIVATE PRACTICE;

EID: 29544446114     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1305     Document Type: Article

References (13)

1. Bishop AJ, Marteau TM, Armstrong D, et al. 2004. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study. Bjog 111: 775-779.
2. Copel JA, Bahado-Singh RO. 1999. Prenatal screening for Down's syndrome-a search for the family's values. N Engl J Med 341: 521-522.
3. Haddow JE, Palomaki GE, Knight GJ, et al. 1998. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. J Med Screen 5: 115-119.
4. Hecht CA, Hook EB. 1996. Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening. Am J Med Genet 62: 376-385.
5. Jenkins TM, Wapner RJ. 1999. Integrated screening for Down's syndrome. N Engl J Med 341: 1935; author reply 1936.
6. Knight GJ, Palomaki GE, Neveux LM, et al. 1998. hCG and the free beta-subunit as screening tests for Down syndrome. Prenat Diagn 18: 235-245.
7. Palomaki GE, Neveux LM, Haddow JE. 1996. Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials? J Med Screen 3: 12-17.
8. Palomaki GE, Kloza EM, Knight GJ. 2005. Patient and health professional acceptance of integrated serum screening for Down syndrome. Semin Perinatol 29: 247-251.
9. Reynolds T, Zimmermann R, Wright E. 1999. Integrated screening for Down's syndrome. N Engl J Med 341: 1935; author reply 1936.
10. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
11. Wald NJ, Rodeck C, Hackshaw AK, et al. 2003. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10: 56-104.
12. Wright D, Bradbury I, Benn P, et al. 2004. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 24: 762-766.
13. Wright DE, Bradbury I. 2005. Repeated measures screening for Down's Syndrome. BJO G 112: 80-83.